Dharm S Patel
Overview
Explore the profile of Dharm S Patel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
132
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Findley A, Middlehurst J, Howse C, Clifford M, Neill W, Tatlock S, et al.
J Patient Rep Outcomes
. 2023 Apr;
7(1):39.
PMID: 37079188
Background: Sleep disturbance, pain, and fatigue are key symptoms/impacts of axial spondyloarthritis (axSpA). Three customized Patient-Reported Outcomes Measurement Information System (PROMIS) Short Forms (Sleep Disturbance, Pain Interference, and Fatigue) have...
2.
Wu J, Hansen J, Patel D, Nyholm N, Veverka K, Swensen A
J Med Econ
. 2020 Oct;
23(12):1501-1502.
PMID: 33040632
No abstract available.
3.
Patel D, Veverka K, Hansen J, Yamauchi P, Alonso-Llamazares J, Lebwohl M
J Clin Aesthet Dermatol
. 2020 Aug;
13(5):12-18.
PMID: 32802249
There are a variety of treatment options currently available for plaque psoriasis affecting the scalp, yet scalp psoriasis remains one of the most frustrating and difficult-to-manage forms of the disease....
4.
Veverka K, Patel D, Anger T, Hansen B, Del Rosso J, Kircik L
J Drugs Dermatol
. 2020 Mar;
19(2):121-126.
PMID: 32129954
Objective: Investigate the effect of fixed-combination calcipotriene 0.005% plus betamethasone dipropionate 0.064% (Cal/BD) foam on target lesion severity in plaque psoriasis.
Design: Post-hoc analysis was conducted on data from a...
5.
Wu J, Hansen J, Patel D, Nyholm N, Veverka K, Swensen A
J Med Econ
. 2020 Jan;
23(6):641-649.
PMID: 31985301
The fixed-dose combination foam formulation of calcipotriene 0.005% plus betamethasone dipropionate 0.064% (Cal/BD) has demonstrated efficacy and a favorable safety profile for the treatment of plaque psoriasis. Recently, a topical...
6.
Misenko S, Patel D, Her J, Bunting S
Cell Cycle
. 2018 Apr;
17(7):881-891.
PMID: 29620483
'BRCAness' is a term used to describe cancer cells that behave similarly to tumors with BRCA1 or BRCA2 mutations. The BRCAness phenotype is associated with hypersensitivity to chemotherapy agents including...
7.
Patel D, Misenko S, Her J, Bunting S
J Cell Biol
. 2017 Sep;
216(11):3521-3534.
PMID: 28912125
The gene product, BLM, is a RECQ helicase that is involved in DNA replication and repair of DNA double-strand breaks by the homologous recombination (HR) pathway. During HR, BLM has...
8.
Li M, Cole F, Patel D, Misenko S, Her J, Malhowski A, et al.
EMBO Rep
. 2016 Sep;
17(11):1532-1541.
PMID: 27670884
BRCA1 mutations strongly predispose affected individuals to breast and ovarian cancer, but the mechanism by which BRCA1 acts as a tumor suppressor is not fully understood. Homozygous deletion of exon...
9.
Simhadri S, Peterson S, Patel D, Huo Y, Cai H, Bowman-Colin C, et al.
J Biol Chem
. 2014 Jul;
289(35):24617-29.
PMID: 25016020
PALB2 links BRCA1 and BRCA2 in homologous recombinational repair of DNA double strand breaks (DSBs). Mono-allelic mutations in PALB2 increase the risk of breast, pancreatic, and other cancers, and biallelic...